Cell culture systems for hepatitis C virus

Current Topics in Microbiology and Immunology

Volumn 369, Issue , 2013, Pages 17-48

  Steinmann, Eike ^a   Pietschmann, Thomas ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ARTICLE; CELL CULTURE; DISEASE COURSE; DRUG DEVELOPMENT; GENOTYPE; HEPATITIS C VIRUS; HOST CELL; HUMAN; LIVER CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RESEARCH; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84876523614     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-27340-7_2     Document Type: Article

References (186)

1. Abe K, Ikeda M et al (2007) Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Res 125(1):88-97
2. Adair R, Patel AH et al (2009) Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA. J Gen Virol 90(Pt 4):833-842
3. Aizaki H, Morikawa K et al (2008) Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol 82(12):5715-5724
4. Akazawa D, Date T et al (2007) CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 81(10):5036-5045
5. Ali S, Pellerin C et al (2004) Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 78(1):491-501
6. Appel N, Herian U et al (2005) Efficient rescue of hepatitis C virus RNA replication by transcomplementation with nonstructural protein 5A. J Virol 79(2):896-909
7. Appel N, Zayas M et al (2008) Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4(3):e1000035
8. Baldick CJ, Wichroski MJ et al (2010) A novel small molecule inhibitor of hepatitis C virus entry. PLoS Pathog 6(9):e1001086
9. Bartenschlager R (2006) Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr Opin Microbiol 9(4):416-422
10. Bartenschlager R, Lohmann V (2000) Replication of hepatitis C virus. J Gen Virol 81(Pt 7):1631-1648
11. Bartosch B, Dubuisson J et al (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197(5):633-642
12. Bauhofer O, Ruggieri A et al. (2012) Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. Gastroenterology 143(2):429-38e8
13. Baumert TF, Ito S et al (1998) Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 72(5):3827-3836
14. Binder M, Kochs G et al (2007) Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46(5):1365-1374
15. Bitzegeio J, Bankwitz D et al (2010) Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog 6:e1000978
16. Blanchard E, Belouzard S et al (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80(14):6964-6972
17. Blight KJ, Kolykhalov AA et al (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290(5498):1972-1974
18. Blight KJ, McKeating JA et al (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76(24):13001-13014
19. Blight KJ, McKeating JA et al (2003) Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77(5):3181-3190
20. Brimacombe CL, Grove J et al (2011) Neutralizing antibody-resistant hepatitis C virus cell-tocell transmission. J Virol 85(1):596-605
21. Buck M (2008) Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One 3(7):e2660
22. Bukh J, Pietschmann T et al (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 99(22):14416-14421
23. Bukh J, Meuleman P et al (2010) Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models. J Infect Dis 201(9):1381-1389
24. Bungyoku Y, Shoji I et al (2009) Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J Gen Virol 90(Pt 7):1681-1691
25. Buonocore L, Blight KJ et al (2002) Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76(14):6865-6872
26. Burgel B, Friesland M et al (2011) Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration. J Viral Hepat 18(8):562-570
27. Cai Z, Zhang C et al (2005) Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 79(22):13963-13973
28. Calland N, Albecka A et al (2012) (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55(3):720-729
29. Carloni G, Iacovacci S et al (1993) Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol Suppl 8:31-39
30. Catanese MT, Ansuini H et al (2010) Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J Virol 84(1):34-43
31. Chan K, Cheng G et al (2012) An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture. Virology 422(2):224-234
32. Chang KS, Cai Z et al (2006) Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J Virol 80(15):7364-7374
33. Chockalingam K, Simeon RL et al (2010) A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. Proc Natl Acad Sci USA 107(8):3764-3769
34. Ciesek S, von Hahn T et al (2011a) The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 54(6):1947-1955
35. Ciesek S, Westhaus S et al (2011b) Impact of intra- and inter-species variation of occludin on its function as coreceptor for authentic hepatitis C virus particles. J Virol 85(15):7613-7621
36. Coller KE, Berger KL et al (2009) RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 5(12):e1000702
37. Date T, Morikawa K et al. (2012) Replication and infectivity of a novel genotype 1b hepatitis C virus clone. Microbiol Immunol 56(5):308-317
38. Date T, Kato T et al (2004) Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem 279(21):22371-22376
39. Decaens C, Durand M et al (2008) Which in vitro models could be best used to study hepatocyte polarity? Biol Cell 100(7):387-398
40. Delgrange D, Pillez A et al (2007) Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88(Pt 9):2495-2503
41. Dreux M, Dao Thi VL et al (2009) Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog 5(2):e1000310
42. Evans MJ, Rice CM et al (2004) Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci USA 101(35):13038-13043
43. Evans MJ, von Hahn T et al (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801-805
44. Fishman SL, Murray JM et al (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 197(4):597-607
45. Fletcher NF, Wilson GK et al. (2012) Hepatitis C virus infects the endothelial cells of the bloodbrain barrier. Gastroenterology 142(3):634-643 e6
46. Fletcher NF, Yang JP et al (2010) Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 139(4):1365-1374
47. Flint M, Thomas JM et al (1999) Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 73(8):6782-6790
48. Flint M, Dubuisson J et al (2000) Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J Virol 74(2):702-709
49. Flint M, von Hahn T et al (2006) Diverse CD81 proteins support hepatitis C virus infection. J Virol 80(22):11331-11342
50. Fournier C, Sureau C et al (1998) In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol 79(Pt 10):2367-2374
51. Frese M, Schwarzle V et al (2002) Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35(3):694-703
52. Friebe P, Boudet J et al (2005) Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. J Virol 79(1):380-392
53. Gottwein JM, Scheel TK et al (2007) Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133(5):1614-1626
54. Gottwein JM, Scheel TK et al (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49(2):364-377
55. Gottwein JM, Jensen TB et al (2011a) Development and application of hepatitis C reporter viruses with genotype 1-7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. J Virol 85(17):8913-8928
56. Gottwein JM, Scheel TK et al (2011b) Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses. Gastroenterology 141(3):1067-1079
57. Grobler JA, Markel EJ et al (2003) Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase. J Biol Chem 278(19):16741-16746
58. Grove J, Nielsen S et al (2008) Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Virol 82(24):12020-12029
59. Gu B, Gates AT et al (2003) Replication studies using genotype 1a subgenomic hepatitis C virus replicons. J Virol 77(9):5352-5359
60. Guo JT, Bichko VV et al (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75(18):8516-8523
61. Haid S, Pietschmann T et al (2009) Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J Biol Chem 284(26):17657-17667
62. Haid S, Windisch MP et al (2010) Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J Virol 84(2):964-975 Recently, claudin- 1 (CLDN1) was identified as a host protein essential
63. Hsu M, Zhang J et al (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 100(12):7271-7276
64. Iacovacci S, Sargiacomo M et al (1993) Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Res Virol 144(4):275-279
65. Ikeda M, Yi M et al (2002) Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76(6):2997-3006
66. Ikeda M, Abe K et al (2005) Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329(4):1350-1359
67. Iro M, Witteveldt J et al (2009) A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antiviral Res 83(2):148-155
68. Ishii K, Murakami K et al (2008) Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochem Biophys Res Commun 371(3):446-450
69. Jensen TB, Gottwein JM et al (2008) Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection. J Infect Dis 198(12):1756-1765
70. Jiang J, Luo G (2012) Cell culture adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious Hepatitis C Virus. J Virol 86(17):8987-8997
71. Jones CT, Murray CL et al (2007) Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81(16):8374-8383
72. Jones DM, Patel AH et al (2009) The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J Virol 83(5):2163-2177
73. Jones CT, Catanese MT et al (2010) Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol 28(2):167-171
74. Kang JI, Kim JP et al (2009) Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity. Virus Res 144(1-2):107-116
75. Kato T, Furusaka A et al (2001) Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol 64(3):334-339
76. Kato N, Sugiyama K et al (2003a) Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306(3):756-766
77. Kato T, Date T et al (2003b) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125(6):1808-1817
78. Kato T, Date T et al (2005) Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol 79(1):592-596
79. Kaul A, Worez I et al (2007) Cellculture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81(23):13168-13179
80. Kaul A, Stauffer S et al (2009) Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog 5(8):e1000546
81. Khromykh AA, Westaway EG (1997) Subgenomic replicons of the flavivirus Kunjin: construction and applications. J Virol 71(2):1497-1505
82. Kishine H, Sugiyama K et al (2002) Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem Biophys Res Commun 293(3):993-999
83. Kobayashi M, Bennett MC et al (2006) Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay. J Virol 80(4):1817-1825
84. Kolykhalov AA, Agapov EV et al (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277(5325):570-574
85. Koutsoudakis G, Kaul A et al (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80(11):5308-5320
86. Koutsoudakis G, Herrmann E et al (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81(2):588-598
87. Koutsoudakis G, Perez-del-Pulgar S et al (2011) Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation. PLoS ONE 6(8):e23587
88. Krey T, d'Alayer J et al (2010) The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog 6(2):e1000762
89. Krieger N, Lohmann V et al (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75(10):4614-4624
90. Lagaye S, Shen H et al (2012) Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection. Hepatology 56(3):861-872
91. Lagging LM, Meyer K et al (1998) Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol 72(5):3539-3546
92. Lambot M, Fretier S et al (2002) Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J Biol Chem 277(23):20625-20630
93. Lanford RE, Guerra B et al (2003) Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77(2):1092-1104
94. Lanford RE, Guerra B et al (2006) Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain. Virology 355(2):192-202
95. Lavillette D, Bartosch B et al (2006) Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J Biol Chem 281(7):3909-3917
96. Lavillette D, Pecheur EI et al (2007) Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol 81(16):8752-8765
97. Lazaro CA, Chang M et al (2007) Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 170(2):478-489
98. Liang C, Rieder E et al (2005) Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells. Virology 333(1):41-53
99. Lin LT, Noyce RS et al (2010) Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liverspecific microRNA 122. J Virol 84(18):9170-9180
100. Lindenbach BD (2010) New cell culture models of hepatitis C virus entry, replication, and virus production. Gastroenterology 139(4):1090-1093
101. Lindenbach BD, Evans MJ et al (2005) Complete replication of hepatitis C virus in cell culture. Science 309(5734):623-626
102. Lindenbach BD, Meuleman P et al (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103(10):3805-3809
103. Lohmann V, Korner F et al (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285(5424):110-113
104. Lohmann V, Korner F et al (2001) Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75(3):1437-1449
105. Lohmann V, Hoffmann S et al (2003) Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 77(5):3007-3019
106. Long G, Hiet MS et al (2011) Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 141(3):1057-1066
107. Lundstrom K (2004) Gene therapy applications of viral vectors. Technol Cancer Res Treat 3(5):467-477
108. Ma Y, Yates J et al (2008) NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82(15):7624-7639
109. Maekawa S, Enomoto N et al (2004) Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells. J Viral Hepat 11(5):394-403
110. Matsuura Y, Tani H et al (2001) Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286(2):263-275
111. McCaffrey K, Gouklani H et al (2011) The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity. J Gen Virol 92(Pt 1):112-121
112. McMullan LK, Grakoui A et al (2007) Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci USA 104(8):2879-2884
113. Mee CJ, Harris HJ et al (2009) Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol 83(12):6211-6221
114. Meertens L, Bertaux C et al (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80(23):11571-11578
115. Michalak JP, Wychowski C et al (1997) Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78(Pt 9):2299-2306
116. Mittelholzer C, Moser C et al (1997) Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell lines. Virus Res 51(2):125-137
117. Miyamoto M, Kato T et al (2006) Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). Intervirology 49(1-2):37-43
118. Molina S, Castet V et al (2008) Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82(1):569-574
119. Molina-Jimenez F, Benedicto I et al (2012) Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology 425(1):31-39
120. Morgello S (2005) The nervous system and hepatitis C virus. Semin Liver Dis 25(1):118-121
121. Mori K, Abe K et al (2008) New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C. Biochem Biophys Res Commun 371(1):104-109
122. Murray EM, Grobler JA et al (2003) Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. J Virol 77(5):2928-2935
123. Murray CL, Jones CT et al (2008a) Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol 6(9):699-708
124. Murray J, Fishman SL et al (2008b) Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol 14(1):17-27
125. Narbus CM, Israelow B et al (2011) HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85(22):12087-12092
126. Ndongo-Thiam N, Berthillon P et al (2011) Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology 54(2):406-417
127. Owsianka A, Tarr AW et al (2005) Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol 79(17):11095-11104
128. Pacini L, Graziani R et al (2009) Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles. J Virol 83(18):9079-9093
129. Parent R, Marion MJ et al (2004) Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126(4):1147-1156
130. Peng B, Xu MYS, Han B, Lee Y-J, Chan K, Tian Y, Pagratis N, Mo H, McHutchison J, Delaney W, Cheng G (2012) Development and molecular characterization of a robust genotype 4 Hepatitis C virus subgenomic replicon. J Hepatol 56(Suppl 2):S322
131. Phan T, Beran RK et al (2009) Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol 83(17):8379-8395
132. Pietschmann T, Lohmann V et al (2001) Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 75(3):1252-1264
133. Pietschmann T, Lohmann V et al (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76(8):4008-4021
134. Pietschmann T, Kaul A et al (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103(19):7408-7413
135. Pietschmann T, Zayas M et al (2009) Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5(6):e1000475
136. Pileri P, Uematsu Y et al (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938-941
137. Ploss A, Evans MJ (2012) Hepatitis C virus host cell entry. Curr Opin Virol 2(1):14-19
138. Ploss A, Khetani SR et al (2010) Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci USA 107(7):3141-3145
139. Podevin P, Carpentier A et al (2010) Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139(4):1355-1364
140. Radkowski M, Wilkinson J et al (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76(2):600-608
141. Reiss S, Rebhan I et al (2011) Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9(1):32-45
142. Roelandt P, Obeid S et al. (2012) Human pluripotent stem cell derived hepatocytes support complete replication of hepatitis C virus. J Hepatol 57(2):246-251
143. Rumin S, Berthillon P et al (1999) Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 80(Pt 11):3007-3018
144. Russell RS, Meunier JC et al (2008) Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci USA 105(11):4370-4375
145. Sainz B Jr, Chisari FV (2006) Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol 80(20):10253-10257
146. Sainz B Jr, TenCate V et al (2009) Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J 6:103
147. Sainz B Jr, Barretto N et al (2012) Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18(2):281-285
148. Sarrazin C, Mihm U et al (2005) Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection. J Infect Dis 192(10):1710-1719
149. Scarselli E, Ansuini H et al (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017-5025
150. Schaller T, Appel N et al (2007) Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81(9):4591-4603
151. Scheel TK, Gottwein JM et al (2008) Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci USA 105(3):997-1002
152. Scheel TK, Gottwein JM et al (2011a) Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85(6):2891-2906
153. Scheel TK, Gottwein JM et al (2011b) Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha. Gastroenterology 140(3):1032-1042
154. Schwartz RE, Trehan K et al (2012) Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci USA 109(7):2544-2548
155. Schwarz AK, Grove J et al (2009) Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization. J Virol 83(23):12407-12414
156. Sieczkarski SB, Whittaker GR (2002) Dissecting virus entry via endocytosis. J Gen Virol 83(Pt 7):1535-1545
157. Spaete RR, Alexander D et al (1992) Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188(2):819-830
158. Steinmann E, Penin F et al (2007) Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 3(7):e103
159. Steinmann E, Brohm C et al (2008) Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 82(14):7034-7046
160. Sumpter R Jr, Loo YM et al (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79(5):2689-2699
161. Tarr AW, Owsianka AM et al (2007) Cloning, expression, and functional analysis of patientderived hepatitis C virus glycoproteins. Methods Mol Biol 379:177-197
162. Timpe JM, Stamataki Z et al (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47(1):17-24
163. Triyatni M, Saunier B et al (2002) Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 76(18):9335-9344
164. Tscherne DM, Jones CT et al (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80(4):1734-1741
165. Uprichard SL, Chung J et al (2006) Replication of a hepatitis C virus replicon clone in mouse cells. Virol J 3:89
166. Vieyres G, Pietschmann T (2012) Entry and replication of recombinant hepatitis C viruses in cell culture. Methods pii: S1046-2023(12)00245-9[Epub ahead of print]
167. Vieyres G, Angus AG et al (2009) Rapid synchronization of hepatitis C virus infection by magnetic adsorption. J Virol Methods 157(1):69-79
168. Wakita T, Pietschmann T et al (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7):791-796
169. Weissenborn K, Tryc AB et al (2009) Hepatitis C virus infection and the brain. Metab Brain Dis 24(1):197-210
170. Wellnitz S, Klumpp B et al (2002) Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. J Virol 76(3):1181-1193
171. Whidby J, Mateu G et al (2009) Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain. J Virol 83(21):11078-11089
172. Wilkinson J, Radkowski M et al (2009) Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 83(3):1312-1319
173. Windisch MP, Frese M et al (2005) Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79(21):13778-13793
174. Witteveldt J, Evans MJ et al (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 90(Pt 1):48-58
175. Wu X, Robotham JM et al (2012) Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation. PLoS Pathog 8(4):e1002617
176. Yanagi M, Purcell RH et al (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94(16):8738-8743
177. Yi M, Lemon SM (2004) Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol 78(15):7904-7915
178. Yi M, Lemon SM (2009) Genotype 1a HCV (H77S) infection system. Methods Mol Biol 510:337-346
179. Yi M, Bodola F et al (2002) Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein. Virology 304(2):197-210
180. Yi M, Villanueva RA et al (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103(7):2310-2315
181. Yi M, Ma Y et al (2007) Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81(2):629-638
182. Zhong J, Gastaminza P et al (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102(26):9294-9299
183. Zhong J, Gastaminza P et al (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80(22):11082-11093
184. Zhu Q, Guo JT et al (2003) Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77(17):9204-9210
185. Zhu H, Dong H et al (2007) Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133(5):1649-1659
186. Zignego AL, Giannini C et al (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39(Suppl 1):S38-S45